# OnCo record paper-liu-geneplus-personalised-mrd-medcomm-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-liu-geneplus-personalised-mrd-medcomm-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-liu-geneplus-personalised-mrd-medcomm-2025" ;
  schema:name "Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies"@en ;
  schema:description "Geneplus' personalised blood test found relapse months before scans in bowel, breast and lung cancer, and the mutations shared by every tumour cell were the most informative."@en ;
  schema:url <https://onco.cc/key-papers/paper-liu-geneplus-personalised-mrd-medcomm-2025/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/mco2.70483>, <https://pubmed.ncbi.nlm.nih.gov/41346570/> ;
  schema:sameAs <https://doi.org/10.1002/mco2.70483> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Liu L, Liang W, Cao W, et al." ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/geneplus-personalised-mrd/> ;
  onco:companies <https://onco.cc/companies/geneplus/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-subclone-attribution-residual-disease/> .